Immunologic reactions 

 

The Gell and Coombs Classification of Immunologic Reactions serves as a foundational framework for understanding immune-mediated reactions, though it's important to note that it doesn't encompass the entirety of complex immune processes. This classification system categorizes immune reactions into four main types, each characterized by distinct mechanisms and clinical presentations.

 

**Type I: Immediate Reactions (IgE Mediated)**

 

In Type I reactions, the immune response is triggered rapidly upon exposure to a specific antigen. This interaction results in the cross-linking of Immunoglobulin E (IgE) antibodies bound to mast cells and basophils. This cross-linking initiates the release of inflammatory mediators, including histamine, leukotrienes, prostaglandins, and tryptase. The immediate release of these substances can lead to symptoms such as urticaria (hives), angioedema (localized swelling), rhinitis (runny nose), wheezing, gastrointestinal distress (diarrhea, vomiting), hypotension (low blood pressure), and in severe cases, anaphylaxis. It typically occurs within minutes of antigen exposure. Late-phase Type I reactions can also manifest, causing symptom recurrence 4 to 8 hours after exposure. Clinical examples encompass allergic conditions like urticaria, allergic rhinitis, insect venom allergies, and various drug or food allergies.

 

**Type II: Cytotoxic Reactions**

 

Type II reactions are mediated by antibodies, predominantly IgG and IgM, which target specific cell surface or tissue antigens. These antigens can be of native, foreign, or hapten nature (small foreign molecules attached to larger native molecules). Antibodies in Type II reactions can destroy cells through opsonization (coating for phagocytosis), complement-mediated lysis, or antibody-dependent cellular cytotoxicity. Clinical examples include conditions like penicillin-induced autoimmune hemolytic anemia (directed at cell surface antigens), Goodpasture disease (directed at tissue antigens, specifically basement membrane components), and myasthenia gravis (directed at tissue antigens, particularly the acetylcholine receptors on muscle cells).

 

**Type III: Immune Complex Reactions**

 

In Type III reactions, exposure to antigens, especially in genetically predisposed individuals, leads to the formation of antigen-antibody complexes. These complexes activate complement and attract neutrophils, resulting in tissue inflammation. Commonly affected areas include the skin, kidneys, joints, and the lymphoreticular system. Clinically, Type III reactions often present with symptoms resembling "serum sickness," which typically occurs 10 to 14 days after exposure. This type of reaction is often associated with the use of β-lactam antibiotics or nonhuman antiserum, such as antithymocyte globulin or antivenoms. Clinical examples encompass conditions like serum sickness and immune complex-mediated vasculitis.

 

**Type IV: Delayed Hypersensitivity Reactions (T-Cell Mediated)**

 

Type IV reactions are T-cell mediated and typically involve the activation of sensitized T cells, particularly CD4+ cells, upon exposure to an antigen. This activation leads to tissue inflammation, but unlike Type I, the response is delayed and typically occurs 48 to 96 hours after exposure. Clinical examples of Type IV reactions include allergic contact dermatitis, often seen in response to substances like poison ivy, and tuberculin sensitivity tests, which are used to diagnose tuberculosis.

 

In summary, the Gell and Coombs Classification offers valuable insights into the diverse ways the immune system responds to antigens, providing a foundation for understanding and categorizing immune-mediated reactions, although it is not an exhaustive representation of the complexity of immune responses.